(Newswire.net — November 26, 2013) Southlake, Texas — Niche Pharmaceuticals Inc. and Steve Brandon are proud to announce that the Dr. recommended magnesium supplement known as Mag-Tab SR (Magnesium –L-lactate dihydrate) has been shown to replete low intracellular magnesium levels which can lead to the lowering of high blood pressure when taken according to reccommended dosages and frequency. The magnesium –L-lactate –dihydrate that is the active component of Mag-Tab SR supplies the benefits without irritation of the digestive tract.
According to Steve Brandon, of the Niche Pharmaceuticals Inc. company, “A deficiency of magnesium is revealed in a number of health conditions, including high blood pressure, digitalis toxicity, cardiac irritability, arrhythmias, and low potassium levels . Lowered levels of magnesium in the body can result in cardiovascular complications, especially in diabetics with increased insulin resistance..”
He continues, “Taking an enhanced highly bioavailable magnesium supplement like Mag-Tab SR reverses the symptoms of the deficiency. It is estimated that over 80% of Americans have inadequate dietary intake of magnesium, and millions of patients/consumers are also being magnesium compromised by many of the drugs they take including diuretics (water pills) and acid blockers. Additional linked conditions include alcoholism, celiac disease, kidney stones and Lyme disease. The need for magnesium is great, because the mineral is so crucial in many of the body systems and processes.”
Migraine headaches, leg cramps, insulin resistance and fatigue, accompanied by problems in metabolizing carbohydrates are part of the menu of symptoms that can be alleviated by choosing an enhanced supplement such as Mag-Tab SR. Experts say users should choose a sustained released magnesium that is absorbed by the body over a 24 hour period of time. This will offer the highest level of benefits.
Learn additional details regarding the advantages of taking magnesium supplements by going to the home pages found at http://www.magtabsr.com/compare/ today. Members of the press and individuals who want further explanations on the contents of this specific press notice are encouraged to contact Steve Brandon at the location which follows.